logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Share:
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for INCY
Kevin Ajenifuja
30 Sep 14 10:18:26
Potential short $INCY
12Stocks.com
30 Sep 14 08:53:35
MidCap #Stocks Performance $DWA $TIBX $IRM $INFA $LGF $SHLD $LPI $NI $CSC $NMBL $ARIA $EPE $INCY $COG more@ http://t.co/tf79gD96D3
FonsieTrader
30 Sep 14 04:45:27
$INCY broke up all EMAs with decent volume! Has also a nice bullish MACD crossover! worth watching http://t.co/vcJDBgWNY1
FonsieTrader
30 Sep 14 04:12:39
Bullish MACD Crossovers 1/2 $AEGR $AGCO $ASTM $BDX $BLDP $CELG $CREE $EGN $EXC $FB $HIMX $INCY $JRJC $KOS http://t.co/ajEB6fcUgp
12Stocks.com
30 Sep 14 03:03:31
Weekly MidCap #Stocks Trend $TIBX $DWA $MU $WTW $CF $STRZA $BRCD $INCY $EPE $RES $AWAY $ENDP $KOS $PAYX $NI @ http://t.co/tf79gD96D3
12Stocks.com
30 Sep 14 03:03:10
Weekly MidCap #Stocks Performance $TIBX $DWA $MU $WTW $CF $VRTX $STRZA $BRCD $ZU $INCY $EPE $RES $BMRN more@ http://t.co/tf79gD96D3
Gotham City Capital
30 Sep 14 02:34:57
RT @wcclubchamp: @TravisMKnight will look into it! Structured around HCV, HBV, NASH, & immuno oncology. Liver & IO: $ACHN, $GILD, $INCY, $A…
Точка Входа.Трейдинг
30 Sep 14 02:30:13
Идеи long / / $CONN $RSPP $INTU $MU $INCY $FDX $BMRN $FB .. http://t.co/ASnGh0TVb0
Wcclubchamp
30 Sep 14 01:25:38
@TravisMKnight will look into it! Structured around HCV, HBV, NASH, & immuno oncology. Liver & IO: $ACHN, $GILD, $INCY, $ARWR, $MGNX, $CLDX
Joe
29 Sep 14 20:37:44
RT @DrPaulyDeSantis: $INCY #ESMO14 “Continue excitement for IDO-1/PD-1 combo’s among others” BMO $RHHBY $BMY $MRK $AZN http://t.co/9jAunMP3…
Dr. Paul DeSantis
29 Sep 14 19:45:59
$INCY #ESMO14 “Continue excitement for IDO-1/PD-1 combo’s among others” BMO $RHHBY $BMY $MRK $AZN http://t.co/9jAunMP3ik
12Stocks.com
29 Sep 14 16:03:24
MidCap #Stocks Trend $DWA $TIBX $INFA $NI $EPE $INCY $INTU $WTW $TSN $MYGN $AWAY $MU $KOS $PF $RES $BRCD @ http://t.co/tf79gD96D3
12Stocks.com
29 Sep 14 16:03:06
MidCap #Stocks Performance $DWA $TIBX $IRM $INFA $LGF $SHLD $LPI $NI $CSC $NMBL $ARIA $EPE $INCY $COG more@ http://t.co/tf79gD96D3
12Stocks.com
29 Sep 14 13:00:38
MidCap #Stocks Performance $TIBX $DWA $ZU $NI $SHLD $NMBL $INFA $ARIA $LGF $LPI $INCY $ALKS $AEO $NSM more@ http://t.co/tf79gD96D3
J. Bob O'Malley
29 Sep 14 13:00:13
@DrPaulyDeSantis Do you still like $INCY? I entered at $49.
theoptiondon
29 Sep 14 12:26:32
@naviavatar Navi's HOT PICKS $GPRO $AGIO $PANW $GEVA $INCY - Platinum Profits
FonsieTrader
29 Sep 14 12:02:28
$INCY Crossed all EMAs with decent volume! has also, a nice bullish MACD Crossover! Long Setup http://t.co/FNurExH3O1
CrockyEntertainment
29 Sep 14 11:24:58
RT @Recce562: Names to watch include: $FOLD, $RPTP, $ACHN, $MNKD, $ELGX, $CPRX, $IMMU, $ARIA, $SNTA, $CLDX, $INCY
BLUESPIDER
29 Sep 14 11:04:38
Names to watch include: $FOLD, $RPTP, $ACHN, $MNKD, $ELGX, $CPRX, $IMMU, $ARIA, $SNTA, $CLDX, $INCY
theoptiondon
29 Sep 14 10:28:50
"@NaviAvatar: $INCY this breakout from bottom looks nice - went long"
Daily Contracts
29 Sep 14 10:01:03
Real-Time feed of company contracts, original agreements and executive updates from Incyte Corporation $INCY http://t.co/KBicQORxY2
12Stocks.com
29 Sep 14 08:53:49
MidCap #Stocks Performance $TIBX $DWA $INFA $ARIA $NMBL $ZU $LGF $SHLD $NI $NSM $LPI $INCY $MYGN $BRCD more@ http://t.co/tf79gD96D3
Market Int Center
29 Sep 14 06:36:40
Potential Incyte $INCY Trade Has 8.85% Downside Protection ( http://t.co/zI8ZthPHTB )
Ticker Report
29 Sep 14 06:25:22
Insider Selling: Incyte EVP Sells 11,111 Shares of Stock $INCY http://t.co/bm6eCQ1NMI
Точка Входа.Трейдинг
29 Sep 14 02:15:08
Покупки / / $ZU 40 $FB 79 $INCY 50 $NUS 45 $NKE 90 / / #трейдинг #nyse #nasdaq #биржа
Rob Hodges
26 Sep 14 17:04:36
RT @BioInvestor2013: @pSividaCorp $PSDV we call it weeks ago Nobody listen !! $OXGN $ecyt $cprx $atrs $srpt $kerx $idix $qcor $inc…
BioInvestor
26 Sep 14 14:20:11
@pSividaCorp $PSDV we call it weeks ago Nobody listen !! $OXGN $ecyt $cprx $atrs $srpt $kerx $idix $qcor $incy $bmrn $pfe $nvs
Thomas Collins
26 Sep 14 14:00:31
$INCY Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma ... http://t.co/TjwORAP4V9
Peter Bardens
26 Sep 14 08:02:25
$INCY Insider Selling: Incyte EVP Sells 11111 Shares of Stock (INCY) http://t.co/CTuQvzwZj5
John Ablemann
26 Sep 14 08:02:23
$INCY Commit To Purchase Incyte Corporation At $40, Earn 10.5% Using Options http://t.co/HO9ESuS8Uv
Sleek Money
26 Sep 14 07:56:39
Incyte EVP James M. Daly Unloads 11,111 Shares $INCY http://t.co/xrKAzP2x7U
Market Int Center
26 Sep 14 05:19:50
Potential Incyte $INCY Trade Has 9.25% Downside Protection ( http://t.co/kZz8k6Svwu )
WKRB News
25 Sep 14 19:39:29
Insider Selling: Incyte EVP Sells 11,111 Shares of Stock $INCY http://t.co/Y6mV0XZqNt
US Banking News
25 Sep 14 19:19:29
Incyte EVP Sells $529,439 in Stock $INCY http://t.co/wTbVIsPCrL
$Stocknewsalerts
25 Sep 14 13:19:50
$INCY ALERT: New Incyte Corporation SEC Filing From our Stock News Alerts App
Market Int Center
25 Sep 14 12:41:23
Incyte $INCY Showing Support Near $46.73 ( http://t.co/ZFZ79N6Phw )
Daily Contracts
25 Sep 14 06:34:01
Real-Time feed of company contracts, original agreements and executive updates from Incyte Corporation $INCY http://t.co/KBicQORxY2
Peter Bardens
25 Sep 14 05:30:53
$INCY Commit To Purchase Incyte Corporation At $40, Earn 10.5% Using Options http://t.co/ajJlxcfKQv
FonsieTrader
25 Sep 14 04:40:27
Parabolic Sar Buy Signals 2/3 $EBAY $FIS $GEVA $GLUU $HAS $HLF $HWAY $ICLR $INCY $MELI $MLM $MNDO $NBG $OGE http://t.co/bCVwyf74KL
finsents
25 Sep 14 04:14:47
$INCY:US 25Sep Positive News #Sentiment http://t.co/WePRccyko1 #NASDAQ
12Stocks.com
24 Sep 14 16:02:57
MidCap #Stocks Performance $BBBY $VRTX $TIBX $ALXN $ZU $STRZA $SCTY $SGEN $INCY $UTHR $JAZZ $HAS $ULTA more@ http://t.co/tf79gD96D3
12Stocks.com
24 Sep 14 14:02:11
MidCap #Stocks Performance $BBBY $VRTX $ALXN $SCTY $ZU $HAS $STRZA $INCY $SGEN $JAZZ $FNF $CBST $ULTA more@ http://t.co/tf79gD96D3
Harry Walkman
24 Sep 14 14:00:31
$INCY Incyte Receives Consensus Rating of "Buy" from Analysts (NASDAQ:INCY) http://t.co/xaUTP3uRU0
Jeffrey Blake
24 Sep 14 13:02:04
$INCY Incyte Receives Consensus Rating of "Buy" from Analysts (NASDAQ:INCY) http://t.co/wSB2ABdInp
Market Int Center
24 Sep 14 12:41:40
Potential Incyte $INCY Trade Has 11.59% Downside Protection ( http://t.co/kuMvnPbUzc )
Keydreaming
24 Sep 14 08:53:49
RT @DozenStocks: MidCap #Stocks Performance $BBBY $STRZA $SCTY $PAYX $INCY $JAZZ $ULTA $MRVL $DATA $VRTX $KMX $LNKD $ANAT more@ http://t.c…
12Stocks.com
24 Sep 14 08:52:36
MidCap #Stocks Performance $BBBY $STRZA $SCTY $PAYX $INCY $JAZZ $ULTA $MRVL $DATA $VRTX $KMX $LNKD $ANAT more@ http://t.co/tf79gD96D3
BioInvest
24 Sep 14 07:59:58
@MTSLNews MTSL stocks trading at low-end of recent trading ranges - $IMGN $INCY $NVAX $PCYC $SGMO see new Issue at http://t.co/bEIx3QdTCG
TickerChirp
24 Sep 14 02:46:04
Hottest Tweets Concerning $INCY on 09/24/2014 http://t.co/i2UNQaMMWB
				
				
  +Follow August 21, 2013 9:20AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.